Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
38,695,728
-
Shares change
-
-1,296,130
-
Total reported value, excl. options
-
$145,493,534
-
Value change
-
+$615,055
-
Put/Call ratio
-
440%
-
Number of buys
-
51
-
Number of sells
-
32
-
Price
-
$3.76
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q4 2020
As of 31 Dec 2020 GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) had 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,695,728 shares of stock of the company.
Largest 10 holders included BVF INC/IL, NEA Management Company, LLC, BlackRock Inc., VANGUARD GROUP INC, Camber Capital Management LP, DIMENSIONAL FUND ADVISORS LP, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, ACADIAN ASSET MANAGEMENT LLC, TWO SIGMA ADVISERS, LP, and TWO SIGMA INVESTMENTS, LP.
This table shows 107 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.